Response: We appreciate the commenters for their input on this issue
Follistatin Gene Therapy Research in Humans Phase 1/2a clinical trial data for AAV1-FS344 in Becker muscular dystrophy patients demonstrated a statistically significant average 11.5% improvement in six-minute walk test performance at 6 months (p = 0.02), with the degree of pre-existing muscle fibrosis at baseline identified as the strongest predictor of treatment response
In this study, 480 PsA patients were randomized to golimumab 2 mg/kg, administered at 0, 2, 4, 12 and 20 weeks, or placebo
If you have ever wondered if these two powerhouses can be taken together or if they might compete for absorption, you are asking the right questions
Toradol may be used for pain-related support, and Zofran may be used for nausea-related support when appropriate after review by licensed medical professionals